Ostea 150 mg filmom obložene tablete
| Name | Ostea 150 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-300307929 |
| Active Substance | natrijev ibandronat hidrat |
| Composition | 1 filmom obložena tableta sadrži 150 mg ibandronatne kiseline u obliku natrijevog ibandronat hidrata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Hrvatska Pharmathen S.A., Pallini Attiki, Grčka |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 27.11.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/01 |
| Registration Number | 381-12-01/30-19-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | M05BA06 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
